China Medicine Corporation
CHME · OTC
9/30/2010 | 6/30/2010 | 3/31/2010 | 12/31/2009 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $2,141 | $4,025 | $1,722 | -$2,167 |
| Dep. & Amort. | $424 | $467 | $462 | $349 |
| Deferred Tax | $0 | $0 | $0 | -$6 |
| Stock-Based Comp. | $140 | $90 | $3 | $30 |
| Change in WC | -$2,488 | -$6,835 | $351 | $10,061 |
| Other Non-Cash | -$563 | -$1,253 | -$1,110 | $5,165 |
| Operating Cash Flow | -$347 | -$3,506 | $1,429 | $13,431 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$4,435 | -$108 | -$64 | $31 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | -$13 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $726 | $69 | $0 | -$6,509 |
| Investing Cash Flow | -$3,709 | -$39 | -$77 | -$6,478 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$1,733 | -$6,559 | $1,906 | -$6,972 |
| Stock Issued | $0 | $0 | $12,000 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,545 | $7,978 | -$4,649 | -$1,759 |
| Financing Cash Flow | $2,811 | $1,419 | $9,257 | -$8,731 |
| Forex Effect | $94 | $44 | $6 | $7 |
| Net Chg. in Cash | -$1,150 | -$2,083 | $10,615 | -$1,771 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $9,004 | $11,087 | $472 | $2,243 |
| End Cash | $7,854 | $9,004 | $11,087 | $472 |
| Free Cash Flow | -$4,782 | -$3,614 | $1,365 | $13,462 |